Reflexiones desde el derecho al mejoramiento neural farmacológico (Neuroenhancement)

Contenido principal del artículo

María Isabel Cornejo Plaza

Resumen

En este texto se reflexiona acerca de las interfaces existentes entre una práctica novedosa denominada mejoramiento neural farmacológico en relación con las neurociencias, neuroética y neuroderecho. Describe los efectos que esta práctica produce en la cognición de sujetos sanos y, cómo su consumo está siendo problematizado por la literatura especializada, a varios niveles. La literatura destaca los aspectos éticos, de jus-ticia distributiva y los jurídicos en las distintas fuentes del derecho, tanto a nivel funcional como conceptual.

Detalles del artículo

Cómo citar
Cornejo Plaza, M. I. (2021). Reflexiones desde el derecho al mejoramiento neural farmacológico (Neuroenhancement). Problema. Anuario De Filosofía Y Teoría Del Derecho, 1(15), 511–546. https://doi.org/10.22201/iij.24487937e.2021.15.16131
Sección
Artículos

Citas

Baddeley, Alan, “Working memory”, CURRENT BIOlogy, 20, 2010.

Benerjee, Dipavo., “Psychopharmacology for Excessive Daytime Sleepiness”, SLEEP MEDICINE REVIEWS, 8, 2004.

Bostrom, Nick., “In Defense of Posthuman Dignity”, BIOETHICS, vol. 19, 2005.

Bublitz, Jan Christoph, “My mind is mine!? Cognitive liberty as a Legal Concept”, COGNITIVE EN-HANCEMENT: AN INTERDISCIPLINARY PERSPECTIVE, Hildt, 2013.

Bublitz, Jan Christoph y MERKEL, Reinhard, “Crimes Against Minds: On Mental Manipulations, Harms and a Human Right to Mental Self-Determination”, CRIMINAL LAW AND PHILOSO-PHY, vol. 8, 2014.

Chul-Han, Byung, PSICOPOLÍTICA. NEOLIBERALISMO Y NUEVAS TÉCNICAS DE PODER, Barcelona, Herder, 2014.

Chandler, Jennifer., “Autonomy and the unintended legal consequences of emerging neuro-therapies”, NEUROETHICS, vol. 6, núm. 6, 2013.

Clarke, Randolph y REED, Thomas, “Free will and Agential Powers”, en SHOEMAKER, D. (ed.), AGENCY AND RESPONSABILITY, vol. 3, Oxford University press, 2015.

Cornejo Plaza, María Isabel, “Biobancos, Desafíos en la protección de muestras almacenadas de datos con fines de investigación biomédica. Perspectiva chilena según acuerdo Trans-Pacific Partnership (TPP)”, REVISTA DE DERECHO Y GENOMA HUMANO. GENÉTICA, BIOTECNO-LOGÍA Y MEDICINA AVANZADA, núm. 47, Dykinson, 2017.

Cornejo PLAZA, María Isabel, Capítulo 12: “Edición genética y eugenesia: nuevas perspectivas éticas y jurídicas”, en Martínez y Lima (ed.), DILEMAS ÉTICOS Y MORALES EN EMBRIONES HUMANOS: ABORDAJE INTERDISCIPLINARIO EN SALUD REPRODUCTIVA, Ascune, 2018.

Cornejo PLAZA, María Isabel, “El mejoramiento neural farmacológico neuroenhancement y el impacto en la esfera de los derechos humanos ¿un desafío para la democracia?”, en VA-LENZUELA, Jonatan (ed.) DESAFÍOS GLOBALES PARA LA DEMOCRACIA, Tirant lo Blanch, 2019.

Derek, Parfit, REASONS AND PERSONS, Oxford, Oxford Clarendon Press, 1984.

Earp, Brian ET AL., “Adicction, Identity, Morality”, PSYARXIV, 2018, disponible en: https://psyarxiv.com/evm84/ (fecha de consulta: 18 de junio de 2020).

Eberbach, Wolfram, “Die Verbesserung des Menschen, Tatsächliche und rechtliche Aspekte der wunscherfüllenden Medizin”, MEDR, núm. 26, 2008.

Farah, Martha et al., “Neurocognitive Enhancement: What Can we do and What Should we do? Nature Reviews”, NEUROSCIENCE, 5, 2004.

Farah, Martha, NEUROETHICS: AN INTRODUCTION WITH READINGS, Hong Kong, MIT Press, 2010.

Franke, Andre Gunder et al., “Non-Medical use of Prescription Stimu-

lants and Illicit Use of Stimulants for Cognitive Enhancement in Pupils and Students in Germany”, PHARMACOPSYCHIATRY, 44, 2011.

Franke, Andre Gunder ET AL., “Use of Illicit and Prescription Drugs for Cognitive or Mood En-hancement Among Surgeons”, BMC MEDICINE, 11, 2013.

Friedman, David, “Does Technology Require New Law?”, HARVARD JOURNAL OF LAW AND PUBLIC POLICY, vol. 25, núm. 2, 2001.

García-López, Eric ET AL., “Neurolaw in Latin America: Current Status and Challenges”, INTER-NATIONAL JOURNAL OF FORENSIC MENTAL HEALTH, 2019.

Glannon, Walter, BRAIN, BODY AND MIND. NEUROETHICS WITH A HUMAN FACE, Nueva York, Oxford University Press, 2011.

Glannon, Walter, “Neuroscience, Free Will, and Responsibility,” JOURNAL OF ETHICS IN MENTAL HEALTH, 4, 2, 2009.

Glannon, Walter, “Our Brains are not Us,” BIOETHICS, 23, 6, 2009.

González MORÁN, Luis, “Implicaciones éticas y jurídicas de las intervenciones de mejora en humanos. Reflexión general”, en ROMEO CASABONA, Carlos María (ed.), MÁS ALLÁ DE LA SA-LUD. INTERVENCIONES DE MEJORA EN HUMANOS, Bilbao, Comares, 2012.

Goold, Imogen y MASLEN, Hannah, “Obliging Surgeons to Enhance Negligence Liability for Un-corrected Fatigue and Problems with Proving Causation”, MEDICAL LAW REVIEW, vol. 23, no. 3, 2014.

Grey, Betsy, “Neuroscience and Emotional Harm in Tort Law: Rethinking the American Ap-proach toFree-Standing Emotional Distress Claim”, LAW AND NEUROSCIENCE: CURRENT LEGAL ISSUES, Oxford, Oxford Univ. Press., 2010.

Greely, Henry, “The Social Effects of Advances in Neuroscience: Legal Problems, Legal Pre-spectives. In Neuroethics: Defining the Issues”, en ILLIS, J. (ed.) THEORY, PRACTICE, AND POLICY, Nueva York, Oxford University Press, 2006.

Greely, Henry, “Neuroscience and Criminal Justice: not Responsibility but Treatment”, KANSAS LAW REVIEW, vol. 56, núm. 11, 2008.

Greely, Henry ET AL., “Towards Responsible Use of Cognitiveenhancing Drugs by the Healthy”, NATURE, 456, 2008.

Greely, Henry ET AL., “Law and the Revolution in Neuroscience: An Early Look at the Field”, AKRON LAW REVIEW, vol. 42, 2008.

Greely, Henry, “What If? The Farther Shores of Neuroethics Commentary on Neuroscience May Supersede Ethics and Law”, SCI ENG ETHICS, 2009.

Hagger, Lynn y HAGGER, Gareth, “Super kids: Regulating the Use of Cognitive and Psychological Enhancement in Children”, LAW, INNOVATION AND TECHNOLOGY, vol. 3, núm 1, 2011.

Hume, David, TRATADO DE LA NATURALEZA HUMANA, Buenos Aires, Orbis-hyspámerica, 1984.

Husain, Masud y MEHTA, Mitul, “Cognitive Enhancement by Drugs in Health and Disease”, TRENDS IN COGNITIVE SCIENCES, 15, 2011.

Kant, Immanuel., FUNDAMENTACIÓN DE LA METAFÍSICA DE LAS COSTUMBRES, Madrid, Espasa-Calpe, 1994.

Kolber, Adam, “Free Will as a Matter of Law”, In PHILOSOPHICAL FOUNDATIONS OF LAW AND NEURO-SCIENCE, Oxford, Oxford University Press, 2016.

Levy, Neil, “Is Neurolaw Conceptually Confused?”, J ETHICS, 18, 2, 2014.

Locke, John, AN ESSAY CONCERNING HUMAN UNDERSTANDING, Oxford, Oxford University Press, 1979.

Lolas STEPKE, Fernando y CORNEJO PLAZA, María Isabel, “Neuroética, Neurociencias y Derecho: Culturas epistémicas y comunidades de práctica”, REVISTA JURISPRUDENCIA ARGENTINA, vol. 7, 2017.

Lynch, Gary, et al., “The Likelihood of Cognitive Enhancement”, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 99, 2011.

Marcus, Gary, THE FUTURE OF THE BRAIN, New Jersey, Princeton Press, 2015.

Minzenberg, Michael y CARTER, Cameron, “Modafinil: a Review of Neurochemical Action and Effects on Cognition”, NEUROPSYCHOPHARMACOLOGY, 33, 2008.

Mohamed, Ahmed, “Does Modafinil Improve Cognitive Functioning in Healthy Individuals?”, en Ruud ter Meulen ET AL. (ed.), RETHINKING COGNITIVE ENHANCEMENT, Oxford Scholar-ship Online, 2017.

Mohamed, Ahmed y Sahakian, Barbara, “The Ethics of Elective Psychopharmacology”, INTER-NATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011.

More, Max, PRINCIPLES OF EXTROPY, Version 3.11, 2003.

Murrow, Gail y Murrow, Richard, “A hypothetical Neurological Association Between Dehu-manization and Human Rights Abuses”, J LAW BIOSCI, vol. 2, núm. 2, 2015.

Nino, Carlos, LA CONSTITUCIÓN DE LA DEMOCRACIA DELIBERATIVA, Barcelona, Gedisa, 1997.

Norman, Claus y BERGER, Mathias, “Neuroenhancment: Status Quo and Perspectives. European Archives of Psychiatry and Clinical”, NEUROSCIENCE, 258, 2008.

O’Sullivan, Siobhán ET AL., “Strasbourg”, REVISTA DE DERECHO Y GENOMA HUMANO. GENÉTICA, BIO-TECNOLOGÍA Y MEDICINA AVANZADA, núm. 47, julio-diciembre de 2017, disponible en: HTTPS://RM.COE.INT/OVIEDO-CONFERENCE-RAPPORTEUR-REPORT-E/168078295C (fecha de consulta: 18 de junio de 2020).

Pardo, Michael y Patterson, Dennis, MINDS, BRAINS, AND LAW. THE CONCEPTUAL FOUNDATIONS OF LAW AND NEUROSCIENCE, Oxford, Oxford University Press, 2013.

Partridge, Bradley ET AL., “Smart Drugs “as Common as Coffee”: Media Hype about Neuroen-hancement”, PLOS ONE, 6, 2011.

Ricoeur, Paul, LO JUSTO, Santiago, Chile, Jurídica, 1995.

Rose, Steven, y Curry, Timothy, “Fatigue Countermeasures, and Performance Enhancement in Rresident Physicians”, MAYO CLINIC PROCEEDINGS, vol. 3, núm. 85, 2010.

Safire, William, NEUROETHICS. MAPPING THE FIELD, Nueva York, The Dana Press, 2002.

Sandberg, Ander y Savulescu, Julian, THE SOCIAL AND ECONOMIC IMPACTS OF COGNITIVE ENHANCE-MENT. IN ENHANCING HUMAN CAPACITIES, Oxford, Wiley-Blackwell, 2011.

Santoni DE SIO, Filippo, ROBICHAUD, Philip y VINCENT, Nicole, “Who Should Enhance? Conceptual and Normative Dimensions of Cognitive Enhancement”, HUMANA. MENTE JOURNAL OF PHILOSOPHICAL STUDIES, vol. 26, 2014.

Savulescu, Julian y SINGER, Peter, “An Ethical Pathway for Gene Editing” BIOETHICS, 33, 2019.

Seatzu, Francesco y FANNI, Simona, “The Experience of the European Court of Human Rights with the European Convention on Human Rights and Biomedicine”, UTRECHT JOURNAL OF INTERNATIONAL AND EUROPEAN LAW, vol. 31, núm. 8, 2015.

Sgarbi, Adrian, “The Mystery of Freedom and Neurolaw”, BEIJING LAW REV, 6, 2015.

Smith, Elizabeth y Farah, Martha, “Are Prescription Stimulants ‘Smart Pills’? The Epidemiology and Cognitive Neuroscience of Does Modafinil Improve Cognitive Functioning in Healthy Individuals?”, PSYCHOLOGICAL BULLETIN 137, 2011.

Vincent, Nicole, “The Challenges Posed to Private Law by Emerging Cognitive Enhance-ment Technologies”, THE LAW OF THE FUTURE AND THE FUTURE OF LAW, Oslo, Torkel Opsahl Academic E Publisher, 2011.